Cancer has been a major cause of death in many countries for decades and enormous efforts are exerted on progress to conquer it worldwide.
InnoBation Bio is a leading company that develops cancer biomarkers and immunotherapies. We are focusing on developments of cancer screening biomarkers for multiple types of cancers, antibody therapeutics including anti-CD47 antibody, and innovative CAR (chimeric antigen receptor) T cell therapies for hematologic and solid cancers.
Our mission is to find track of human immune system, to develop innovative products on biomarkers and biotherapies, and to work through cancer disease with patients and clinicians.